An ISO 9001:2008 Company According to WHO and GMP Standards

Folic acid supplementation reduces stroke risk in patients with hypertension

Folic acid supplementation may have important implications for stroke prevention in patients with hypertension, according to results from the China Stroke Primary Prevention Trial (CSPPT).
Adding folic acid (0.8 mg/day) to enalapril (10 mg/day) reduced the risk of first stroke in Chinese adults with hypertension by 21 percent (p=0.003) compared to treatment with enalapril alone.